Rare Clinical Manifestation of Tardive Dyskinesia In Schizophrenic Patient on Quetiapine and Sertraline: A Case Report
Objective: To underscore the rarity of tardive dyskinesia manifestation in a schizophrenic patient, prescribed second-generation DRBA agents, quetiapine and SSRI sertraline. Background: Tardive dyskinesia is…Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease
Objective: To know whether EEG could be a neural indicator that distinguish between Drug-induced parkinsonism (DIP) and Parkinson’s disease (PD). Background: DIP is the second…Case Report: Carbamazepine-Induced Dystonia, Tremor and Negative Myoclonus
Objective: The objective of this case presentation is mainly to raise awareness of possible side effects of Carbamazepine in epileptic and non-epileptic patients, even years…Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy
Objective: We describe a patient who developed amantadine-induced craniofacial myoclonus with speech impairment. Few cases have been reported [1], thus we offer an additional case…Association Between Motor Symptoms and Autonomic Dysfunction in De Novo Parkinson’s Disease: Insights into the Role of the Gut-Brain Axis
Objective: This retrospective study aimed to investigate the relationship between motor symptoms and autonomic dysfunction in patients with de novo Parkinson's disease(PD). Background: Dysautonomia in…The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson’s Disease Attending an Outpatient Clinic
Objective: The central aim of this cross-sectional study is to define the cognitive and affective contributors to balance control assessment in a cohort of people…Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database
Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…Clinical and epidemiological profile of Parkinson’s disease in India
Objective: To study the clinical profile and risk factors of Parkinson’s disease (PD) in India. Background: The current knowledge of clinical and epidemiological profile of…Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort
Objective: To determine the impact of gastrointestinal symptoms on NMF in PD among Mexican individuals living with PD (PwP). Background: The growing interest in the…Speech features in Korean Parkinson’s disease patients: A prospective cohort study
Objective: In this study, we explored speech characteristics of Korean Parkinson's disease (PD) patients and their usefulness as a biomarker. Background: Previous studies have shown…
- « Previous Page
- 1
- …
- 119
- 120
- 121
- 122
- 123
- …
- 1554
- Next Page »